4-aminopyridine
RxNorm 897018
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 897018 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 4-aminopyridine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
4-aminopyridine
(Atom ID: 10795039)
INPrescribable
Ingredient (IN):
Dalfampridine
(Atom ID: 3052450)
PTPrescribable
Designated preferred name (PT):
Dalfampridine
(Atom ID: 10800655)
PTPrescribable
Designated preferred name (PT):
Dalfampridine-containing product
(Atom ID: 11436290)
SYPrescribable
Synonym (SY):
Fampridine
(Atom ID: 9270567)
SYPrescribable
Synonym (SY):
Fampridine
(Atom ID: 2856860)
FNPrescribable
Full form of descriptor (FN):
Fampridine (substance)
(Atom ID: 10802806)
SYPrescribable
Synonym (SY):
Fampridine-containing product
(Atom ID: 11436707)
FNPrescribable
Full form of descriptor (FN):
Product containing fampridine (medicinal product)
(Atom ID: 11438432)
Patient Education
Dalfampridine
Dalfampridine is used to improve walking in people who have multiple sclerosis (MS; a disease in which the nerves do not function properly and may cause weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control). Dalfampridine may be used alone or with other medications that control the symptoms of MS. Dalfampridine is in a class of medications called potassium channel blockers. It works by strengthening the signals sent by the brain through nerves that have been damaged by MS.
[Learn More]
* Please review the disclaimer below.